30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Medtronic PLC (MDT)

Track

Over the last 90 days, Medtronic PLC has seen significant insider selling, with a net value of -$336,965.44. Notably, EVP Harry Skip Kiil executed multiple sell transactions totaling over $673,000. The company's stock has experienced a 7.3% decrease in the past 90 days, trading near its 52-week low.
Stock chart
Ticker: MDT Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
KIIL HARRY SKIP
EVP & President Cardiovascular
3 sales — total 300,000 USD
Sale 8 Jun 2026
Value US$240,309.58 | Price 310.94 | Shares 70,014
Sale 8 Jun 2026
Value US$2,700,463.77 | Price 43.56 | Shares 95,759
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 80.44 | Shares 1,000
Sale 19 Feb 2026
Value US$1,215,711.11 | Price 395.51 | Shares 78,586
Sale 19 Feb 2026
Value US$3,260,280.79 | Price 34.50 | Shares 51,437
Sale 19 Feb 2026
Value US$1,882,561.35 | Price 97.77 | Shares 19,255
Sale 19 Feb 2026
Value US$2,985,374.81 | Price 97.66 | Shares 30,568
Sale 19 Feb 2026
Value US$161,273.28 | Price 97.86 | Shares 1,648
Proposed sale 19 Feb 2026
Value US$5,132,217.35 | Price 97.71 | Shares 52,524
Sale 19 Nov 2025
Value US$51,040.00 | Price 102.08 | Shares 500
Sale 19 Nov 2025
Value US$33,169.50 | Price 102.06 | Shares 325
Sale 19 Nov 2025
Value US$23,165.35 | Price 102.05 | Shares 227
Sale 19 Nov 2025
Value US$84,183.00 | Price 102.04 | Shares 825
Sale 19 Nov 2025
Value US$203,549.85 | Price 102.03 | Shares 1,995
Sale 19 Nov 2025
Value US$198,064.58 | Price 101.99 | Shares 1,942
Sale 19 Nov 2025
Value US$2,465,278.98 | Price 101.93 | Shares 24,186
Proposed sale 19 Nov 2025
Value US$3,058,452.26 | Price 101.95 | Shares 30,000
Sale 3 Sep 2025
Value US$18,318.00 | Price 91.59 | Shares 200
Sale 3 Sep 2025
Value US$769,729.90 | Price 91.58 | Shares 8,405
Proposed sale 3 Sep 2025
Value US$788,048.74 | Price 91.58 | Shares 8,605
Buy 25 Aug 2025
Value US$230,925.00 | Price 92.37 | Shares 2,500
Buy 22 Aug 2025
Value US$231,825.00 | Price 92.73 | Shares 2,500
Proposed sale 6 Jun 2025
Value US$1,595,469.10 | Price 86.81 | Shares 18,378
Sale 24 Jan 2025
Value US$1,119,330.00 | Price 90.00 | Shares 12,437
Proposed sale 24 Jan 2025
Value US$1,119,330.00 | Price 90.00 | Shares 12,437
Sale 8 Jan 2025
Value US$241,230.00 | Price 80.41 | Shares 3,000
Sale 8 Jan 2025
Value US$550,808.50 | Price 80.41 | Shares 6,850
Proposed sale 8 Jan 2025
Value US$792,038.50 | Price 80.41 | Shares 9,850
Proposed sale 31 Oct 2024
Value US$2,691,794.32 | Price 89.73 | Shares 30,000
Proposed sale 30 Oct 2024
Value US$1,358,740.32 | Price 90.58 | Shares 15,000
Proposed sale 29 Oct 2024
Value US$1,367,348.21 | Price 91.16 | Shares 15,000
Proposed sale 24 Oct 2024
Value US$2,100,632.88 | Price 92.49 | Shares 22,712
Proposed sale 23 Oct 2024
Value US$2,188,205.37 | Price 91.76 | Shares 23,848
Proposed sale 18 Oct 2024
Value US$4,479,309.77 | Price 91.74 | Shares 48,825
Proposed sale 17 Oct 2024
Value US$4,958,717.65 | Price 89.87 | Shares 55,179
Proposed sale 26 Aug 2024
Value US$240,120.00 | Price 90.00 | Shares 2,668
Sale 7 Jun 2024
Value US$133,609.08 | Price 83.82 | Shares 1,594
Sale 7 Jun 2024
Value US$1,467,391.44 | Price 83.76 | Shares 17,519
Proposed sale 7 Jun 2024
Value US$1,601,101.59 | Price 83.77 | Shares 19,113
Sale 8 Apr 2024
Value US$71,001.56 | Price 83.14 | Shares 854
Sale 21 Feb 2024
Value US$1,364,899.20 | Price 85.12 | Shares 16,035
Sale 21 Feb 2024
Value US$1,112,569.90 | Price 85.15 | Shares 13,066
Sale 21 Feb 2024
Value US$135,585.64 | Price 85.06 | Shares 1,594
Proposed sale 21 Feb 2024
Value US$2,613,202.10 | Price 85.13 | Shares 30,695
Planned sale 19 Dec 2023
Value US$410,603.49 | Price 82.17 | Shares 4,997
Proposed sale 19 Dec 2023
Value US$410,603.49 | Price 82.17 | Shares 4,997
Sale 23 Aug 2023
Value US$838,400.00 | Price 83.84 | Shares 10,000
Proposed sale 23 Aug 2023
Value US$838,442.07 | Price 83.84 | Shares 10,000
Planned sale 14 Aug 2023
Value US$83,380.00 | Price 83.38 | Shares 1,000
Proposed sale 14 Aug 2023
Value US$83,380.00 | Price 83.38 | Shares 1,000
Planned sale 4 Aug 2023
Value US$113,716.72 | Price 84.11 | Shares 1,352
Proposed sale 4 Aug 2023
Value US$113,716.72 | Price 84.11 | Shares 1,352
Planned sale 14 Jul 2023
Value US$175,940.00 | Price 87.97 | Shares 2,000
Proposed sale 14 Jul 2023
Value US$175,940.00 | Price 87.97 | Shares 2,000
Sale 10 Jul 2023
Value US$320,865.48 | Price 86.58 | Shares 3,706
Sale 10 Jul 2023
Value US$156,554.72 | Price 86.59 | Shares 1,808
Proposed sale 10 Jul 2023
Value US$477,440.36 | Price 86.59 | Shares 5,514
Sale 13 Dec 2022
Value US$1,338,735.63 | Price 80.50 | Shares 16,631
Sale 14 Oct 2022
Value US$196,014.95 | Price 81.54 | Shares 2,404
Planned sale 18 Mar 2022
Value US$75,020.00 | Price 110.00 | Shares 682
Sale 11 Mar 2022
Value US$631,800.00 | Price 105.30 | Shares 6,000
Buy 16 Dec 2021
Value US$517,332.60 | Price 103.26 | Shares 5,010
Planned sale 6 Dec 2021
Value US$75,020.00 | Price 110.00 | Shares 682
Planned sale 30 Sep 2021
Value US$6,221,027.26 | Price 126.58 | Shares 49,147
Sale 25 Aug 2021
Value US$977,516.10 | Price 134.09 | Shares 7,290
Sale 25 Aug 2021
Value US$2,832,976.32 | Price 134.08 | Shares 21,129
Planned sale 2 Aug 2021
Value US$526,080.00 | Price 131.52 | Shares 4,000
Planned sale 15 Jun 2021
Value US$75,304.35 | Price 124.47 | Shares 605
Planned sale 1 Jun 2021
Value US$316,717.11 | Price 128.07 | Shares 2,473
Planned sale 28 May 2021
Value US$4,389,182.40 | Price 126.65 | Shares 34,656
Planned sale 5 Apr 2021
Value US$1,106,069.64 | Price 118.83 | Shares 9,308
Planned sale 5 Apr 2021
Value US$285,667.32 | Price 118.83 | Shares 2,404
Planned sale 15 Mar 2021
Value US$75,283.84 | Price 119.12 | Shares 632
Sale 2 Mar 2021
Value US$845,680.64 | Price 117.98 | Shares 7,168
Sale 28 Dec 2020
Value US$1,723,500.00 | Price 114.90 | Shares 15,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-08 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
70,014 +16.9%
310.94
US$240,310 		70,014 +16.9% 310.94 US$240,310
2026-06-09 2026-06-08 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
95,759 -46.7%
43.56
US$2,700,464 		95,759 -46.7% 43.56 US$2,700,464
2026-06-08 2026-06-08 PrS Proposed sale
2.5
KIIL HARRY SKIP

Officer

Officer
61,820
400.32
US$3,953,970 		61,820 400.32 US$3,953,970
2026-02-26 2026-02-19 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
385 -1.2%
97.82
US$37,661 		385 -1.2% 97.82 US$37,661
2026-02-26 2026-02-19 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
668 -2.0%
97.83
US$65,347 		668 -2.0% 97.83 US$65,347
2026-02-26 2026-02-19 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
19,255 -36.3%
97.77
US$1,882,561 		19,255 -36.3% 97.77 US$1,882,561
2026-02-26 2026-02-19 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
30,568 -36.5%
97.66
US$2,985,375 		30,568 -36.5% 97.66 US$2,985,375
2026-02-26 2026-02-19 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
1,648 -1.9%
97.86
US$161,273 		1,648 -1.9% 97.86 US$161,273
2026-02-19 2026-02-19 PrS Proposed sale
2.5
KIIL HARRY SKIP

Officer

Officer
52,524
97.71
US$5,132,217 		52,524 97.71 US$5,132,217
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
500 -1.1%
102.08
US$51,040 		500 -1.1% 102.08 US$51,040
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
325 -0.7%
102.06
US$33,170 		325 -0.7% 102.06 US$33,170
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
227 -0.5%
102.05
US$23,165 		227 -0.5% 102.05 US$23,165
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
825 -1.7%
102.04
US$84,183 		825 -1.7% 102.04 US$84,183
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
1,995 -4.0%
102.03
US$203,550 		1,995 -4.0% 102.03 US$203,550
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
1,942 -3.7%
101.99
US$198,065 		1,942 -3.7% 101.99 US$198,065
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
24,186 -31.8%
101.93
US$2,465,279 		24,186 -31.8% 101.93 US$2,465,279
2025-11-19 2025-11-19 PrS Proposed sale
3.4
Smith Gregory L

Officer

Officer
30,000
101.95
US$3,058,452 		30,000 101.95 US$3,058,452
2025-09-05 2025-09-03 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
200 -0.6%
91.59
US$18,318 		200 -0.6% 91.59 US$18,318
2025-09-05 2025-09-03 S Sale
2.5
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
8,405 -19.0%
91.58
US$769,730 		8,405 -19.0% 91.58 US$769,730
2025-09-03 2025-09-03 PrS Proposed sale
2.5
KIIL HARRY SKIP

Officer

Officer
8,605
91.58
US$788,049 		8,605 91.58 US$788,049
2025-08-25 2025-08-25 B Purchase
2.4
Jellison William R
Non-Executive Director
2,500 +100.0%
92.37
US$230,925 		2,500 +100.0% 92.37 US$230,925
2025-08-25 2025-08-22 B Purchase
2.4
Jellison William R
Non-Executive Director
2,500 +inf%
92.73
US$231,825 		2,500 +inf% 92.73 US$231,825
2025-06-06 2025-06-06 PrS Proposed sale
3.2
Salmon Sean

Officer

Officer
18,378
86.81
US$1,595,469 		18,378 86.81 US$1,595,469
2025-01-27 2025-01-24 S Sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
12,437 -23.3%
90.00
US$1,119,330 		12,437 -23.3% 90.00 US$1,119,330
2025-01-24 2025-01-24 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
12,437
90.00
US$1,119,330 		12,437 90.00 US$1,119,330
2025-01-10 2025-01-08 S Sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
3,000 -6.9%
80.41
US$241,230 		3,000 -6.9% 80.41 US$241,230
2025-01-10 2025-01-08 S Sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
6,850 -13.5%
80.41
US$550,808 		6,850 -13.5% 80.41 US$550,808
2025-01-08 2025-01-08 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
9,850
80.41
US$792,038 		9,850 80.41 US$792,038
2024-10-31 2024-10-31 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
30,000
89.73
US$2,691,794 		30,000 89.73 US$2,691,794
2024-10-30 2024-10-30 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
15,000
90.58
US$1,358,740 		15,000 90.58 US$1,358,740
2024-10-29 2024-10-29 PrS Proposed sale
2.9
PARKHILL KAREN L

Former BOD
15,000
91.16
US$1,367,348 		15,000 91.16 US$1,367,348
2024-10-24 2024-10-24 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
22,712
92.49
US$2,100,633 		22,712 92.49 US$2,100,633
2024-10-23 2024-10-23 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
23,848
91.76
US$2,188,205 		23,848 91.76 US$2,188,205
2024-10-18 2024-10-18 PrS Proposed sale
2.9
PARKHILL KAREN L

Former BOD
48,825
91.74
US$4,479,310 		48,825 91.74 US$4,479,310
2024-10-17 2024-10-17 PrS Proposed sale
2.9
PARKHILL KAREN L

Former BOD
55,179
89.87
US$4,958,718 		55,179 89.87 US$4,958,718
2024-08-26 2024-08-26 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Officer

Officer
2,668
90.00
US$240,120 		2,668 90.00 US$240,120
2024-06-11 2024-06-07 S Sale
1.9
Martha Geoffrey

Chairman and CEO

Executive Director
1,594 -1.1%
83.82
US$133,609 		1,594 -1.1% 83.82 US$133,609
2024-06-11 2024-06-07 S Sale
1.9
Martha Geoffrey

Chairman and CEO

Executive Director
17,519 -10.8%
83.76
US$1,467,391 		17,519 -10.8% 83.76 US$1,467,391
2024-06-07 2024-06-07 PrS Proposed sale
1.9
Martha Geoffrey

Officer; Director

Executive Director
19,113
83.77
US$1,601,102 		19,113 83.77 US$1,601,102
2024-04-09 2024-04-08 S Sale
2.7
Marinaro Michael

EVP & President, Surgical OU

Officer
854 -3.0%
83.14
US$71,002 		854 -3.0% 83.14 US$71,002
2024-02-23 2024-02-21 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
16,035 -24.9%
85.12
US$1,364,899 		16,035 -24.9% 85.12 US$1,364,899
2024-02-23 2024-02-21 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
13,066 -16.9%
85.15
US$1,112,570 		13,066 -16.9% 85.15 US$1,112,570
2024-02-23 2024-02-21 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
1,594 -2.0%
85.06
US$135,586 		1,594 -2.0% 85.06 US$135,586
2024-02-21 2024-02-21 PrS Proposed sale
3.2
Salmon Sean

Officer

Officer
30,695
85.13
US$2,613,202 		30,695 85.13 US$2,613,202
2023-12-20 2023-12-19 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
4,997 -14.7%
82.17
US$410,603 		4,997 -14.7% 82.17 US$410,603
2023-12-19 2023-12-19 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
4,997
82.17
US$410,603 		4,997 82.17 US$410,603
2023-08-25 2023-08-23 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
10,000 -17.6%
83.84
US$838,400 		10,000 -17.6% 83.84 US$838,400
2023-08-23 2023-08-23 PrS Proposed sale
3.4
Smith Gregory L

Officer

Officer
10,000
83.84
US$838,442 		10,000 83.84 US$838,442
2023-08-16 2023-08-14 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
1,000 -2.9%
83.38
US$83,380 		1,000 -2.9% 83.38 US$83,380
2023-08-14 2023-08-14 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
1,000
83.38
US$83,380 		1,000 83.38 US$83,380
2023-08-07 2023-08-04 PlS Planned sale
2.7
Marinaro Michael

EVP & President, Surgical OU

Officer
1,352 -4.5%
84.11
US$113,717 		1,352 -4.5% 84.11 US$113,717
2023-08-04 2023-08-04 PrS Proposed sale
2.7
Marinaro Michael

Officer

Officer
1,352
84.11
US$113,717 		1,352 84.11 US$113,717
2023-07-18 2023-07-14 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
2,000 -7.7%
87.97
US$175,940 		2,000 -7.7% 87.97 US$175,940
2023-07-14 2023-07-14 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
2,000
87.97
US$175,940 		2,000 87.97 US$175,940
2023-07-12 2023-07-10 S Sale
2.3
TEN HOEDT ROB

EVP and Pres. Global Regions

Officer
3,706 -7.8%
86.58
US$320,865 		3,706 -7.8% 86.58 US$320,865
2023-07-12 2023-07-10 S Sale
2.3
TEN HOEDT ROB

EVP and Pres. Global Regions

Officer
1,808 -4.0%
86.59
US$156,555 		1,808 -4.0% 86.59 US$156,555
2023-07-10 2023-07-10 PrS Proposed sale
2.3
TEN HOEDT ROB

Officer

Officer
5,514
86.59
US$477,440 		5,514 86.59 US$477,440
2022-12-16 2022-12-13 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
16,631 -31.5%
80.50
US$1,338,736 		16,631 -31.5% 80.50 US$1,338,736
2022-10-17 2022-10-14 S Sale
2.3
TEN HOEDT ROB

EVP and Pres. Global Regions

Officer
2,404 -5.2%
81.54
US$196,015 		2,404 -5.2% 81.54 US$196,015
2022-03-21 2022-03-18 PlS Planned sale
2.9
PARKHILL KAREN L

EVP & Chief Financial Officer

Officer
682 -1.9%
110.00
US$75,020 		682 -1.9% 110.00 US$75,020
2022-03-14 2022-03-11 S Sale
2.5
Surface Carol A

SVP, Chief HR Officer

Officer
6,000 -17.4%
105.30
US$631,800 		6,000 -17.4% 105.30 US$631,800
2021-12-17 2021-12-16 B Purchase
3.7
ANDERSON RICHARD H
Non-Executive Director
5,010 +4.8%
103.26
US$517,333 		5,010 +4.8% 103.26 US$517,333
2021-12-07 2021-12-06 PlS Planned sale
2.9
PARKHILL KAREN L

EVP & Chief Financial Officer

Officer
682 -1.9%
110.00
US$75,020 		682 -1.9% 110.00 US$75,020
2021-10-01 2021-09-30 PlS Planned sale
1.0
Lerman Bradley E

SVP General Counsel & Corp Sec

Officer
49,147 -50.2%
126.58
US$6,221,027 		49,147 -50.2% 126.58 US$6,221,027
2021-08-26 2021-08-25 S Sale
3.2
Salmon Sean

EVP & Pres Diabetes/Cardiovasc

Officer
7,290 -17.9%
134.09
US$977,516 		7,290 -17.9% 134.09 US$977,516
2021-08-26 2021-08-25 S Sale
3.2
Salmon Sean

EVP & Pres Diabetes/Cardiovasc

Officer
21,129 -38.8%
134.08
US$2,832,976 		21,129 -38.8% 134.08 US$2,832,976
2021-08-04 2021-08-02 PlS Planned sale
1.0
Lerman Bradley E

SVP General Counsel & Corp Sec

Officer
4,000 -7.7%
131.52
US$526,080 		4,000 -7.7% 131.52 US$526,080
2021-06-17 2021-06-15 PlS Planned sale
2.9
PARKHILL KAREN L

EVP & Chief Financial Officer

Officer
605 -0.7%
124.47
US$75,304 		605 -0.7% 124.47 US$75,304
2021-06-02 2021-06-01 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
2,473 -10.3%
128.07
US$316,717 		2,473 -10.3% 128.07 US$316,717
2021-06-01 2021-05-28 PlS Planned sale
Liddicoat John R

EVP & President of Americas

Officer
34,656 -44.9%
126.65
US$4,389,182 		34,656 -44.9% 126.65 US$4,389,182
2021-04-07 2021-04-05 PlS Planned sale
1.9
Martha Geoffrey

CEO

Executive Director
9,308 -10.2%
118.83
US$1,106,070 		9,308 -10.2% 118.83 US$1,106,070
2021-04-07 2021-04-05 PlS Planned sale
1.9
Martha Geoffrey

CEO

Executive Director
2,404 -2.9%
118.83
US$285,667 		2,404 -2.9% 118.83 US$285,667
2021-03-16 2021-03-15 PlS Planned sale
2.9
PARKHILL KAREN L

EVP & Chief Financial Officer

Officer
632 -0.7%
119.12
US$75,284 		632 -0.7% 119.12 US$75,284
2021-03-03 2021-03-02 S Sale
2.3
TEN HOEDT ROB

EVP & President EMEA

Officer
7,168 -14.1%
117.98
US$845,681 		7,168 -14.1% 117.98 US$845,681
2020-12-30 2020-12-28 S Sale
2.5
Surface Carol A

SVP, Chief HR Officer

Officer
15,000 -30.5%
114.90
US$1,723,500 		15,000 -30.5% 114.90 US$1,723,500
Explore more

More insider trading research around Medtronic PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America